Alvarado-Esquivela C, Loera-Moncivaisa N, Hernandez-Tinocob J, Sanchez-Anguianob LF, Hernandez-Madridc G, Rabago-Sancheza E et al (2017) Lack of association between Toxoplasma gondii infection and diabetes mellitus: a matched case-control study in a Mexican population. J Clin Med Res 9:508–511
Article
CAS
Google Scholar
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care. 31:62–69
Article
Google Scholar
Bessman AN, Sapico FL (1992) Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors. J Diabetes Complications 6:258–262
Article
CAS
PubMed
Google Scholar
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butle PC (2013) Beta–cell deficit and increased beta–cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Article
Google Scholar
Carter CJ (2013) Toxoplasmosis and polygenic disease susceptibility genes: extensive Toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Path. 965046
Centers for Disease Control and Prevention (2015) Parasites – toxoplasmosis (toxoplasma infection). CDC, Atlanta http://www.cdc.gov/parasites/toxoplasmosis/epi.html. Accessed 18 July 2019
Google Scholar
Centers for Disease Control and Prevention (2017) Neglected parasitic infections (NPIs) in the United States. CDC, Atlanta http://www.cdc.gov/parasites/npi/index.html. Accessed 18 July 2019
Google Scholar
Cong W, Liu GH, Meng QF, Dong W, Qin SY, Zhang FK et al (2015) Toxoplasma gondii infection in cancer patients: prevalence risk factors genotypes and association with clinical diagnosis. Cancer Lett. 259:307–313
Article
CAS
Google Scholar
Del Grande C, Galli L, Schiavi E, Dell’Osso L, Brusch F (2017) Toxoplasma gondii a trigger of bipolar disorder? Pathogens 6. https://doi.org/10.3390/pathogens6010003
Article
PubMed Central
CAS
Google Scholar
DerSimonian R, Laird N (1986) Meta–analysis in clinical trials. Control Clin Trials. 7:177–188
Article
CAS
PubMed
Google Scholar
Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler R et al (2005) Mechanisms of β–cell death in type 2 diabetes. Diabetes. 54:S108
Article
CAS
PubMed
Google Scholar
Dupey JP (2008) The history of Toxoplasma gondii – the first 100 years. J Eukaryot Microbiol. 55:467–475
Article
Google Scholar
Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW et al (2011) Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care. 34:1424–1430
Article
PubMed
PubMed Central
Google Scholar
Flegr J (2013) Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol. 216:127–133
Article
PubMed
Google Scholar
Gokce C, Yazar S, Bayram F, Gundogan K, Yaman O, Sahin I (2008) Anti–Toxoplasma gondii antibodies in type 2 diabetes. Nat Med J India. 21:51
Google Scholar
Gonzalez-Perez A, Schlienger RG, Rodríguez LA (2010) Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs a population–based cohort study. Diabetes Care 33:2580–2585
Article
PubMed
PubMed Central
Google Scholar
Halonen SK, Weiss LM (2013) Toxoplasmosis. In: Garcia HH, Tanowitz HB, Del Brutto OH (eds) Handbook of clinical neurology Vol. 114 (3rd series) Neuroparasitology and Tropical Neurology. Elsevier B.V, Amsterdam, Netherlands, pp 125–145
Chapter
Google Scholar
Han Y, Nie L, Ye X, Zhou Z, Huang S, Zeng C et al (2018) The association between Toxoplasma gondii infection and hypertensive disorders in T2DM patients: a case-control study in the Han Chinese population. Parasit Res. 117:689–695
Article
Google Scholar
Hassanain MA, El-Fadaly HA, Hassanain NA (2014) Toxoplasma gondii parasite load elevation in diabetic rats as latent opportunistic character. Ann Trop Med Pub Health 7:110–115
Google Scholar
Hemida MH, Shahat SAR, Bayoumy AMS, Mohammad AD (2017) Prevalence of toxoplasmosis among diabetic patients. Euro J Pharm Med Res. 4:137–140
Google Scholar
Henriques SA, Brett R, Alexander J, Pratt J, Roberts CW (2009) Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomod. 16:122–113
Article
CAS
Google Scholar
International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edition. IFD, Brussels, Belgium
Google Scholar
Kankova S, Sulc J, Flegr J (2010) Increased pregnancy weight gain in women with latent toxoplasmosis and RhD-positivity protection against this effect. Parasitology. 137:1773–1779
Article
CAS
PubMed
Google Scholar
Khalili M, Mahami-Oskouei M, Shahbazi A, Safaiyan A, Mohammadzadeh-Gheshlaghi N, Mahami-Oskouei L (2018) Correlation between serum levels of anti-Toxoplasma gondii antibodies and the risk of diabetes. Iran J of Parasit. 13:637–642
Google Scholar
Li Y, Xin H, Zhang X, Wei C, Duan Y, Wang H, et al. Toxoplasma gondii infection in diabetes mellitus patients in China: seroprevalence, risk factors, and case–control studies. BioMed Res Int. 2018; https://doi.org/10.1155/2018/4723739
ADS
Google Scholar
Majidiani H, Dalvand S, Daryani A, Galvan-Ramirez ML, Foroutan-Rad M (2016) Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta–analysis of case–control studies. Braz J Infec Dis. 20:605–609
Article
Google Scholar
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Instit. 22:719–748
CAS
Google Scholar
Modrek MJ, Saravani R, Mousavi M, Khorashad AS, Piri M (2015a) Investigation of IgG and IgM antibodies against Toxoplasma gondii among diabetic patients. Int J Infect. 2:e27595
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLOS Med. 2009; https://doi.org/10.1371/journalpmed1000097.
Molan A, Nosaka K, Hunter M, Wang W (2018) A systemic review and meta–analysis of human case–control studies examining the association between Toxoplasma gondii and type 2 diabetes mellitus. Am J Life Sci Res. 6:106–122
Google Scholar
Molan AL, Ismail MH. Study the possible association between toxoplasmosis and diabetes mellitus in Iraq. WJPPS. 2017; https://doi.org/10.20959/wjpps20173-8721.
Nazligulm Y, Sabuncu T, Ozbilge H (2001) Is there a predisposition to intestinal parasitosis in diabetic patients? Diabetes Care. 24:1503–1504
Article
Google Scholar
Nihad SF, Hamad SS (2017) Seroprevalence of Toxoplasma gondii infection in diabetic patients at Kirkuk province. IJSBAR. 36:157–165
Google Scholar
Oz H (2014) Toxoplasmosis, pancreatitis, obesity, and drug discovery. Pancreat Disord Ther. 4:138
PubMed
PubMed Central
Google Scholar
Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 39:1385–1394
Article
PubMed
Google Scholar
Pradhan A (2007) Obesity metabolic syndrome and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev. 65:152–156
Article
Google Scholar
Prandota J. T. gondii infection acquired during pregnancy and/or after birth may be responsible for development of both type 1 and 2 diabetes mellitus. J Diabetes Metab. 2013; https://doi.org/10.4172/2155-6156.1000241.
Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA (2011) The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 6:e23866
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Reeves GM, Mazaheri S, Snitker S, Langenberg P, Giegling I, Hartmann A, et al. A positive association between T. gondii seropositivity and obesity. Front Public Health. 2013;1: https://doi.org/10.3389/fpubh.2013.00073.
Saheb E (2017) Detection of toxoplasmosis infection in diabetic patients. Diyala J Med. 1:70–74
Google Scholar
Saki J, Shafieenia S (2016) Foroutan–Rad M. Seroprevalence of toxoplasmosis in diabetic pregnant women in southwestern of Iran. J Parasit Dis. 40:4586–1589
Article
Google Scholar
Shirbazou S, Delpisheh A, Mokhetari R, Tavakoli G (2013) Serologic detection of anti Toxoplasma gondii infection in diabetic patients. Iran Red Crescent Med J. 15:701–703
Article
PubMed
PubMed Central
Google Scholar
Siyadatpanah A, Tabatabaie F, Oormazdi H, Meamar AH, Razmjou E, Hadighi R et al (2013) Comparison of anti–toxoplasma IgG and IgM antibodies determined by ELISA method in diabetic and non-diabetic individuals in west Mazandaran province, Iran, 2011–2012. Ann Bio Res. 4:281–285
Google Scholar
Waree P (2008) Toxoplasmosis: pathogenesis and immune response. Thammasat Med J. 8:487–496
Google Scholar
World Health Organization (2014) Global status report on noncommunicable diseases 2014. WHO, Geneva https://www.who.int/nmh/publications/ncd–status–report–2014/en/. Accessed 12 July 2019
Google Scholar
World Health Organization (2016) Global health estimates: deaths by cause, age, sex and country, 2000–2016. WHO, Geneva https://www.who.int/healthinfo/global_burden_disease/en/. Accessed 15 July 2019
Google Scholar